Plain-English translation of NCT06271577 on ClinicalTrials.gov ↗ · Source last updated ·
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing a new AliveCor 12-lead ECG System—a smartphone-based device that records your heart's electrical activity—to see if it can diagnose heart attacks just as accurately as the standard hospital heart machines. Researchers will compare the smartphone device readings side-by-side with traditional hospital ECG machines in people who come to the emergency department with chest pain symptoms.
Heart attacks need to be diagnosed within minutes to start life-saving treatment quickly. This trial exists to see whether this portable smartphone device could help doctors identify heart attacks faster and more conveniently, especially in settings where traditional machines may not be immediately available.
You likely qualify if…
You likely don't qualify if…
If you qualify, you would have one additional heart scan using the new AliveCor smartphone device while you are being evaluated in the emergency department. The study team will make sure this smartphone scan does not delay any of your regular emergency care or tests. Your smartphone reading will be compared with your standard hospital heart machine reading to help researchers validate the new technology.
AI-generated summary from trial data · Jul 7, 2026 · Not medical advice
United States
United Kingdom